Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen synthesis upregulation" refers to the biological process in which the production of collagen proteins is increased, usually through enhanced transcription, translation, or post-translational modification of collagen genes. Collagen, the most abundant structural protein in mammals, plays a central role in tissue strength, extracellular matrix composition, and overall connective tissue function. This synthesis is tightly regulated at multiple levels, involving transcription of COL genes, translation of propeptide chains, and extensive post-translational modifications such as hydroxylation, glycosylation, triple-helix formation, and extracellular assembly into fibrils[1][2][3][4][5][6][7]. Upregulation can be physiological (wound healing, tissue remodeling) or pathological (fibrosis, scar formation, organ dysfunction).
Enzyme cofactor (ascorbic acid/vitamin C is essential for prolyl and lysyl hydroxylase activity); Inhibition of growth factors (e.g., TGF-beta inhibition reduces fibrotic collagen production); Anti-fibrotic (inhibition of key steps in pathological collagen synthesis/secretion)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen synthesis upregulation.